Immunosuppressive therapies for the twenty-first century.
Schmouder
R L
RL
Department of Clinical Pharmacology, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
D000818:Animals; D015815:Cell Adhesion Molecules / Q000037:antagonists & inhibitors; D002454:Cell Differentiation; D015316:Genetic Therapy; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods / Q000639:trends*; D007166:Immunosuppressive Agents / Q000145:classification / Q000627:therapeutic use*; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D011685:Purine Nucleotides / Q000037:antagonists & inhibitors; D015398:Signal Transduction; D014181:Transplantation Immunology
D015815:Cell Adhesion Molecules; D007166:Immunosuppressive Agents; D011685:Purine Nucleotides